Free Trial

UNITY Biotechnology (UBX) SEC Filings & 10K Form

UNITY Biotechnology logo
$0.18 -0.12 (-40.43%)
Closing price 07/8/2025
Extended Trading
$0.18 0.00 (0.00%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent UNITY Biotechnology SEC Filings

DateFilerForm TypeView
07/17/2025
3:06 PM
Jalbert Craig R. (Reporting)
UNITY Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/30/2025
7:00 AM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
7:00 AM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
3:30 PM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
3:31 PM
UNITY Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/11/2025
3:10 PM
UNITY Biotechnology (Filer)
Form 10-K/A
03/24/2025
6:00 AM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:00 AM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:02 AM
Hashad Yehia (Reporting)
UNITY Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
7:03 AM
Hashad Yehia (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:31 PM
UNITY Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
3:40 PM
UNITY Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2025
3:30 PM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
3:33 PM
Nguyen Alexander Hieu (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:35 PM
Sullivan Lynne Marie (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:07 PM
Nguyen Alexander Hieu (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:03 PM
Ghosh Anirvan (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Sullivan Lynne Marie (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:35 PM
Grossi Federico (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:30 PM
Grossi Federico (Reporting)
UNITY Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2025
7:00 AM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Nguyen Alexander Hieu (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
3:10 PM
Sullivan Lynne Marie (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
3:10 PM
Ghosh Anirvan (Reporting)
UNITY Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:30 PM
UNITY Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:31 PM
UNITY Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:UBX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners